A detailed history of Cardinal Capital Management transactions in Becton Dickinson & CO stock. As of the latest transaction made, Cardinal Capital Management holds 26,275 shares of BDX stock, worth $5.98 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares
26,275
Previous 23,571 11.47%
Holding current value
$5.98 Million
Previous $5.75 Million 13.12%
% of portfolio
1.07%
Previous 1.1%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$233.45 - $247.73 $631,248 - $669,861
2,704 Added 11.47%
26,275 $6.5 Million
Q4 2023

Jan 26, 2024

BUY
$232.24 - $267.23 $17,418 - $20,042
75 Added 0.32%
23,571 $5.75 Million
Q3 2023

Oct 16, 2023

BUY
$254.9 - $283.59 $93,548 - $104,077
367 Added 1.59%
23,496 $6.07 Million
Q2 2023

Jul 12, 2023

BUY
$238.39 - $265.32 $70,086 - $78,004
294 Added 1.29%
23,129 $6.11 Million
Q1 2023

Apr 18, 2023

BUY
$229.71 - $259.35 $62,710 - $70,802
273 Added 1.21%
22,835 $5.65 Million
Q4 2022

Jan 20, 2023

SELL
$218.29 - $256.91 $5,020 - $5,908
-23 Reduced 0.1%
22,562 $0
Q3 2022

Oct 21, 2022

BUY
$51.03 - $264.23 $12,196 - $63,150
239 Added 1.07%
22,585 $5.03 Million
Q2 2022

Aug 04, 2022

BUY
$234.74 - $275.42 $85,680 - $100,528
365 Added 1.66%
22,346 $5.51 Million
Q1 2022

Apr 21, 2022

BUY
$243.64 - $270.48 $183,948 - $204,212
755 Added 3.56%
21,981 $5.85 Million
Q4 2021

Jan 18, 2022

BUY
$230.08 - $250.94 $8,052 - $8,782
35 Added 0.17%
21,226 $5.34 Million
Q3 2021

Oct 21, 2021

SELL
$232.72 - $256.47 $50,267 - $55,397
-216 Reduced 1.01%
21,191 $5.21 Million
Q2 2021

Jul 14, 2021

BUY
$232.65 - $254.58 $43,505 - $47,606
187 Added 0.88%
21,407 $5.21 Million
Q1 2021

Apr 19, 2021

BUY
$232.09 - $256.88 $30,635 - $33,908
132 Added 0.63%
21,220 $5.16 Million
Q4 2020

Feb 01, 2021

BUY
$221.92 - $245.94 $147,132 - $163,058
663 Added 3.25%
21,088 $5.28 Million
Q3 2020

Oct 16, 2020

BUY
$215.77 - $276.76 $38,191 - $48,986
177 Added 0.87%
20,425 $4.75 Million
Q2 2020

Jul 16, 2020

SELL
$219.9 - $263.41 $1,539 - $1,843
-7 Reduced 0.03%
20,248 $4.84 Million
Q1 2020

Apr 20, 2020

SELL
$195.69 - $279.01 $98,627 - $140,621
-504 Reduced 2.43%
20,255 $4.65 Million
Q4 2019

Jan 21, 2020

SELL
$236.45 - $266.82 $56,038 - $63,236
-237 Reduced 1.13%
20,759 $5.65 Million
Q3 2019

Oct 18, 2019

BUY
$230.58 - $256.08 $11,529 - $12,804
50 Added 0.24%
20,996 $5.31 Million
Q2 2019

Jul 08, 2019

SELL
$217.4 - $246.08 $39,132 - $44,294
-180 Reduced 0.85%
20,946 $5.28 Million
Q1 2019

Apr 11, 2019

BUY
$206.05 - $248.17 $4,327 - $5,211
21 Added 0.1%
21,126 $5.28 Million
Q4 2018

Jan 15, 2019

BUY
$204.73 - $257.93 $44,631 - $56,228
218 Added 1.04%
21,105 $4.76 Million
Q3 2018

Oct 25, 2018

SELL
$233.07 - $256.0 $38,456 - $42,240
-165 Reduced 0.78%
20,887 $5.45 Million
Q2 2018

Jul 25, 2018

SELL
$208.1 - $233.85 $3.44 Million - $3.87 Million
-16,544 Reduced 44.0%
21,052 $5.04 Million
Q1 2018

Apr 25, 2018

SELL
$205.46 - $240.27 $412,769 - $482,702
-2,009 Reduced 5.07%
37,596 $8.15 Million
Q4 2017

Feb 01, 2018

BUY
$189.0 - $222.64 $1.99 Million - $2.34 Million
10,521 Added 36.17%
39,605 $8.48 Million
Q3 2017

Oct 24, 2017

BUY
$186.89 - $198.9 $5.44 Million - $5.78 Million
29,084
29,084 $5.7 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Cardinal Capital Management Portfolio

Follow Cardinal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.